1q3d
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1q3d" size="450" color="white" frame="true" align="right" spinBox="true" caption="1q3d, resolution 2.20Å" /> '''GSK-3 Beta complexe...)
Next diff →
Revision as of 16:43, 12 November 2007
|
GSK-3 Beta complexed with Staurosporine
Overview
GSK-3beta is a regulatory serine/threonine kinase with a plethora of, cellular targets. Consequently, selective small molecule inhibitors of, GSK-3beta may have a variety of therapeutic uses including the treatment, of neurodegenerative diseases, type II diabetes and cancer. In order to, characterize the active site of GSK-3beta, we determined crystal, structures of unphosphorylated GSK-3beta in complex with selective and, non-selective ATP-mimetic inhibitors. Analysis of the inhibitors', interactions with GSK-3beta in the structures reveals how the enzyme can, accommodate a number of diverse molecular scaffolds. In addition, a, conserved water molecule near Thr138 is identified that can serve a, functional role in inhibitor binding. Finally, a comparison of the, interactions made by selective and non-selective inhibitors highlights, residues on the edge of the ATP binding-site that can be used to obtain, inhibitor selectivity. Information gained from these structures provides a, promising route for the design of second-generation GSK-3beta inhibitors.
About this Structure
1Q3D is a Single protein structure of sequence from Homo sapiens with STU as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.
Reference
Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors., Bertrand JA, Thieffine S, Vulpetti A, Cristiani C, Valsasina B, Knapp S, Kalisz HM, Flocco M, J Mol Biol. 2003 Oct 17;333(2):393-407. PMID:14529625
Page seeded by OCA on Mon Nov 12 18:50:03 2007
